Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00215371 · ClinicalTrials.gov registry record · Phase 2
Study in Patients With Asthma
A Phase 2 study of Asthma, sponsored by Dey.
- Completed
- Registry status
- Phase 2
- Development phase
- 32
- Enrollment target
- 2
- Study locations
NCT00215371 is a Phase 2 study of Asthma that has completed, run by Dey. The registered enrollment target is 32 participants, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (98% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT00215371, a Phase 2 study of Asthma, has completed, sponsored by Dey.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 32 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to determine which dose of the investigational drug is safest and most effective compared to the control group.
Conditions Studied
Interventions
- DRUG Formoterol Fumarate
Study Locations (2)
California
- Research Site - Long Beach
Oregon
- Research Site - Medford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2002-07 |
| Est. Completion | 2005-11 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00215371
The ClinicalTrials.gov registry entry for NCT00215371 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (98% lower). The listed sponsor is Dey, which has 21 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Asthma appearing as the primary indexed condition, and to 1 intervention - of which Formoterol Fumarate is the first listed.
NCT00215371 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, Oregon.
Frequently Asked Questions
What is clinical trial NCT00215371 about?
NCT00215371 is a clinical study titled "Study in Patients With Asthma". The purpose of this study is to determine which dose of the investigational drug is safest and most effective compared to the control group.
What is the current status of trial NCT00215371?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 32 participants. The study started on 2002-07. Estimated completion is 2005-11.
What conditions does trial NCT00215371 study?
This clinical trial studies the following conditions: Asthma.
What interventions are being tested in trial NCT00215371?
The interventions under investigation include: Formoterol Fumarate (DRUG).
Who is sponsoring clinical trial NCT00215371?
This trial is sponsored by Dey, which has 21 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00215371 being conducted?
This trial has 2 study locations across California, Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Escitalopram in Asthma Patients With Frequent Exacerbation
RECRUITING · Phase 2
-
Metformin IN Asthma for Overweight and Obese Individuals (MINA)
RECRUITING · Phase 2
-
Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma
RECRUITING · Phase 2
-
ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults
RECRUITING · Phase 2
-
A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma
RECRUITING · Phase 2
-
Supplementing L-citrulline to Overweight Late Asthma oNset Phenotypes
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.